We offer a complete integrated solution for the development and manufacturing of lateral flow assays and reader systems.
Developing the next generation of rapid diagnostic products to meet the market need for simple to use, rapid, cost effective, portable systems.
Rapid diagnostic device for the quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light chains (FLCs).
Understand why the use of #lateralflow #rapiddiagnostics is on the increase and will continue to increase over the… https://t.co/JM3VLBclQ3
18 July 2019
© Abingdon Health 2019